Geneva, Switzerland

Michel Dubois-Dauphin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michel Dubois-Dauphin: Innovator in Stem Cell Research

Introduction

Michel Dubois-Dauphin is a prominent inventor based in Geneva, Switzerland. He has made significant contributions to the field of stem cell research, particularly in the area of cell proliferation and gene therapy. His innovative work has the potential to impact medical treatments and regenerative medicine.

Latest Patents

Michel Dubois-Dauphin holds a patent titled "Elimination of proliferating cells from stem cell-derived grafts." This patent provides methods and compositions for a suicide gene approach, which includes an expression vector driven by a cell cycle-dependent promoter. The invention aims to render proliferative cells sensitive to a prodrug after transplantation while avoiding the expression of the suicide gene in post-mitotic cells, such as neurons. He has 1 patent to his name.

Career Highlights

Throughout his career, Michel has been associated with the Research Development Foundation, where he has focused on advancing research in stem cell applications. His work has garnered attention for its innovative approach to addressing challenges in cell therapy.

Collaborations

Michel has collaborated with notable colleagues, including Karl-Heinz Krause and Vannary Tieng Caulet. These partnerships have contributed to the development of groundbreaking research in the field.

Conclusion

Michel Dubois-Dauphin is a key figure in stem cell research, with a focus on innovative solutions for cell proliferation challenges. His contributions continue to shape the future of regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…